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ABSTRACT
Objectives The use of more medicalised labels can 
increase both concern about illness and the desire 
for more invasive treatment. This study analyses the 
media’s coverage of an Analysis article in The BMJ which 
generated a large amount of high- profile international 
media coverage. It aims to understand how to better 
communicate messages about low- risk cancers and 
overdiagnosis to the public.
Design Content analysis of media coverage.
Setting Media was identified by Isentia Media Portal, 
searched in Google News and cross- checked in Factiva 
and Proquest databases from August 2018.
Methods Media headlines, full text and open access 
public comments responding to the coverage on the article 
proposing to ‘rename low- risk conditions currently labelled 
as cancer’ were analysed to determine the main themes.
Results 45 original media articles and their associated 
public comments (n=167) were identified and included 
in the analysis. Overall, headlines focused on cancer 
generally and there was little mention of ‘low- risk’, 
‘overdiagnosis’ or ‘overtreatment’. The full text generally 
presented a more balanced view of the evidence and were 
supportive of the proposal, however, public responses 
tended to be more negative towards the idea of renaming 
low- risk cancers and indicated confusion. Comments 
seemed to focus on the headlines rather than the full 
article.
Conclusions This study offers a novel insight into 
media coverage of the complex and counterintuitive 
problem of overdiagnosis. Continued deliberation on 
how to communicate similar topics to the public through 
the mainstream media is needed. Future work in the 
area of low- risk cancer communication should consider 
the powerful impact of people’s previous experience 
with a cancer diagnosis and the criticism about being 
paternalistic and concealing the truth from patients.
INTRODUCTION
Over the past few decades, our understanding 
of cancer has changed. Evidence now demon-
strates that some cancers are non- growing or 
so slow growing that they will never cause 
harm to an individual if left undetected or 
untreated. This has raised growing concern 
about overdiagnosis in cancer.1 2 Overdi-
agnosis is broadly agreed to be a diagnosis 
that causes more harm than good,3 and can 
result in subsequent overtreatment. While 
there is now evidence of overdiagnosis across 
a number of types of low- risk cancers, the 
strongest evidence has been shown in local-
ised prostate cancer (Gleason ≤6),4 low- grade 
ductal carcinoma in situ (DCIS) of the breast5 
and low- risk papillary thyroid cancer.6
Given the potential harms of overtreatment 
of these low- risk cancers, active monitoring 
is now recognised as a safe and effective 
management option. In localised prostate 
cancer active monitoring has been a recom-
mended management option for a number 
of years, while in low- risk papillary thyroid 
cancer it has recently been suggested for 
very low- risk tumours7 and is currently being 
evaluated in randomised trials internation-
ally for low- grade DCIS.8–10 However, while 
conservative management approaches, such 
as active monitoring, are becoming an option 
for some patients with low- risk cancer, there 
is still a strong perception that aggressive 
immediate treatments are always required.11 
The cancer label currently used to describe 
these low- risk conditions can affect patient’s 
psychological responses and make it harder 
for clinicians to recommend and patients to 
choose active monitoring as a management 
option because of a strong fear of cancer and 
assumption that surgery is best.12–16 Patients, 
therefore, risk being overtreated resulting in 
Strengths and limitations of this study
 ► This is the first study to analyse the media and pub-
lics’ response to a proposal to rename low- risk can-
cers, a potential strategy to reduce overdiagnosis 
and overtreatment.
 ► The article received a large amount of high- profile 
international media coverage which allowed reach 
in a diverse range of audiences.
 ► Much of the radio and television (TV) media was not 
accessible following broadcast so was not able to be 
included in the analysis.
 ► Comments analysed came from a small proportion 
of the total reader/viewership and may therefore 
not be representative of the overall public’s view on 
these topics.
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important surgical side effects and consequences on their 
quality of life.
In 2018 we wrote an Analysis article in The BMJ17 
proposing removal of the cancer label for low- risk lesions 
where there is evidence of overdiagnosis and previous 
calls to replace the term cancer. The article generated 
significant high- profile media coverage internationally, 
including in major national newspapers and on televi-
sion such as British Broadcasting Corporation (BBC) 
World news. The majority of what people know or learn 
about health now comes from media, which presents a 
major challenge for communicating about complex and 
counterintuitive concepts such as overdiagnosis. Previous 
research on the media has shown inaccurate coverage of 
published scientific papers,18 and overstate the benefits 
while downplaying the harms of medicine.19 All of this can 
shape the way people think about their own health.20 21 
This study aims to analyse the media’s coverage of the 
article, and responses to that coverage, to understand 
how to better communicate messages about low- risk 
cancers and overdiagnosis to the public.
METHODS
Study design
A content analysis22 of the media coverage of and initial 
public comments on our BMJ article proposing to 
‘rename low- risk conditions currently labelled as cancer’ 
was conducted. We chose to conduct this analysis as 
the article received a significant amount of unexpected 
media attention, which is quite rare in response to one 
Analysis article. Content analysis combines qualitative 
and quantitative methods to analyse text data. It allows for 
the content and frequency of categories to be reported 
and is commonly used to analyse media. The study team 
included public health researchers with an interest in 
reducing overdiagnosis and overtreatment, a health 
psychologist, an epidemiologist and an endocrinologist.
Procedure
International media referring to the Analysis article 
were identified by Isentia Media Portal and provided 
to study authors by The University of Sydney’s media 
team. Insentia is a subscribed service that collates media 
(online, print, broadcast and social media). Study authors 
also conducted a comprehensive search in Google News 
in the year following publication (August 2018–August 
2019) and ran searches in Factiva and Proquest (both 
Australia and New Zealand Newstream and International 
Newstream) electronic databases from August 2018. 
Media on similar topics23 24 that were not directly related 
to The BMJ Analysis article were excluded. An academic 
librarian with expertise in systematic search design assisted 
with developing a search strategy to specifically capture 
media relating only to the Analysis article which used 
explicit keywords such as cancer, low- risk, overtreatment, 
anxiety, rename, The BMJ, Nickel, McCaffery, Moynihan, 
The University of Sydney. The database searches covered 
newspapers (print and online), webnews, major world 
and academic publications, blogs, magazines, broad-
cast (TV and radio), podcast transcripts and wire feeds/
services. Any additional media that was found in Google 
News, Factiva and Proquest was included in the analysis.
We extracted and analysed three domains across each 
media source: the headline, the full text of the media 
report and all available open access public comments 
responding to the coverage, in order to determine the 
main themes. Only original media sources were included 
with any duplicates published on other sources excluded. 
Replies to original public comments were also excluded.
Patient and public involvement
No patients involved. Open access public comments were 
analysed.
Analysis
The analysis followed an iterative process involving 
three members of the study team. First, the data were 
collated in Excel and organised by type of media. Next, 
two researchers (BN, RM) independently reviewed a 
subset of the article headlines, full text of articles and 
public comments (where applicable) and generated a 
list of recurring themes. These themes were discussed 
among the two researchers and checked by an additional 
research (KM) resulting in the development of an initial 
coding framework. The framework included separate 
codes for the headlines, full text and comments. Full text 
and comments could have more than one theme applied. 
In addition, we analysed and coded for the article’s and 
comments overall support for the proposal to remove the 
cancer label for low- risk cancers, overall opposition to the 
proposal, or overall neutrality (neither supporting nor 
opposing the proposal). Due to their brevity, it was too 
difficult to classify the headlines into overall support or 
oppose categories.
The framework was tested by the two researchers and 
adjusted with further testing and discussion before being 
finalised. BN applied the final coding framework to all 
of the data (article headlines, full text of stories and 
comments), with RM double coding >20%. The level of 
agreement was tested using Cohen’s kappa and indicated 
a strong level of agreement (k=0.86). Any discrepancies 
were discussed until a consensus was obtained. BN quan-
tified coding categories and then compared the themes 
across the three categories to identify any differences 
or similarities. Descriptive statistical analysis was used to 
assess the frequency of each code and short quotations 
from the media text and public comments illustrating a 
diverse range of the themes are presented in the results.
RESULTS
A total of 132 media articles were identified. Articles 
were excluded if they were duplicates, that is, identical 
articles published on a different source (n=49), had only 
published the original press release (n=14) or could not be 
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accessed by the study authors or their media team (n=24). 
This left 45 original media articles and news stories across 
various media sources (online supplementary appendix 
1) and their associated public comments (n=167) to be 
included in the analysis (table 1). The majority of media 
articles were from online news sites (44%) and were from 
Australia and New Zealand (51%). Only 14 of the 45 
(31%) articles had public comments available.
Headlines
Table 2 outlines the main coded themes in the headlines 
and provides an example and the frequency of each theme. 
The media headlines tended to focus on cancer generally, 
with some describing cancer as the ‘c word’ and only a few 
of the headlines using the terms ‘low- risk’ which was used 
in the title of the original Analysis article published in 
The BMJ. Questioning, rethinking or debating cancer was 
the most prominent theme (35.6%) that was identified in 
the headlines, followed by the idea that doctors are being 
told to or should avoid using the word cancer (20.0%). 
There was only one headline (2.2%) from an academic 
media source that used the word ‘overdiagnosis’ and only 
6.7% of the media sources mentioned ‘overtreatment’, 
with a combined 11.1% mentioning anxiety and/or over-
treatment. As expected, the headlines were short (mean 
word count=10) and catchy, but did not always reflect 
the underlying message of the article that removing 
the cancer label in low- risk conditions that are unlikely 
to cause harm if left untreated may help reduce overdi-
agnosis and overtreatment, for example ‘Doctors being 
asked to stop using the ‘c- word’.
Article full text
Table 3 outlines the main coded themes in the full text 
and provides an example and the frequency of each 
theme. The comprehensiveness in reporting of the Anal-
ysis article varied with the mean word count of the media 
articles and news stories was 608 words (ranging from 160 
to 1594 words).
The majority (n=33, 73.3%) of the media’s articles 
and news stories supported the proposal to rename low- 
risk cancers, while only one (2.2%) strongly opposed 
the proposal and 11 (24.4%) were neutral and did not 
seem to support the proposal or oppose it. The latter arti-
cles and news stories gave a quite balanced view of the 
proposal stating both the arguments for and criticisms 
against. All of the articles discussed the evidence that 
points to the need for change and discussed the nega-
tive impact that the cancer label can have. In most of the 
media this consisted of a statement that recent evidence 
demonstrates that the term cancer can lead to higher 
levels of anxiety and greater preferences for more invasive 
treatments. It also included evidence on how our under-
standing of cancer has changed in recent years and now 
shows that some cancers can be non- growing or so slow 
growing that they will never cause harm if left untreated. 
The importance of the need for further discussion and 
deliberation about renaming low- risk cancers and feasi-
bility of changing the terminology (ie, it has been done 
before) were also mentioned in about a quarter (26.6% 
and 24.4%, respectively) of the media.
The main opposing view highlighted in 24.4% of the 
media was the idea that providing better public education 
and communication to patients that all cancers aren’t the 
same. The articles discussed that there are varying levels 
of risk and alternative less invasive treatment options 
Table 1 Characteristics of the media coverage included in 
the analysis (n=45)
Media characteristics Frequency n (%)
Type of media
  Online news site 20 (44.4)
  Online newspaper 11 (24.4)
  Newspaper (print) 6 (13.3)
  Television news 3 (6.7)
  Academic media site 2 (4.4)
  Online magazine 1 (2.2)
  Radio 1 (2.2)
  Blog 1 (2.2)
Country
  Australia and New Zealand 23 (51.1)
  UK and Europe 8 (17.8)
  USA and Canada 6 (13.3)
  Asia 3 (6.7)
  Middle East 3 (6.7)
  South America 2 (4.4)
Public comments available
  Yes 14 (31.1)
  No 31 (68.9)
Table 2 Example and frequency of headline themes (n=45)
Theme description Example %
Questioning cancer/re- thinking cancer/debate on 
cancer
‘Rethinking the word cancer: study calls for low- risk forms of 
the disease’
35.6
Doctors told to/doctors should ‘Doctors should avoid saying ‘cancer’ for minor diagnoses’ 20.0
Push for change or overhaul by researchers ‘Push for cancer diagnosis overhaul’ 17.8
Reduce anxiety and/or overtreatment ‘Drop the C- word to reduce anxiety and overtreatment’ 11.1
Other ‘Give patients the full truth on cancer: RACGP president elect’ 15.6
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available instead of relabelling all low- risk cancers. The 
idea that changing the name of low- risk conditions 
would be concealing the truth from patients, and doctors 
concerns about follow- up and not taking the diagnosis 
as seriously were also highlighted as opposing views 
(discussed in 20.0% and 13.3% of the media, respectively).
Comments
Table 4 outlines the main coded themes in the comments 
and provides an example and the frequency of each 
theme. The public comments were less supportive 
towards the idea of renaming low- risk cancers, with 
approximately half (49.7%) opposing the proposal. 
The themes for opposing the proposal varied, with the 
idea that ‘cancer is cancer’ (19.2%), and the need for 
better education and communication for the public and 
patients (18.6%) being the main two opposing themes. 
Comments coded in these themes discussed the idea 
that changing the terminology would be misleading 
and it would be better to simple educate and commu-
nicate that cancer does not necessarily mean death and 
there can be varying risks. The need to reduce unnec-
essary anxiety and overtreatment was the main theme 
for supporting the renaming proposal. 13.2% of the 
comments acknowledged that the ‘cancer’ label may 
make patients anxious and more inclined to prefer 
more invasive treatments. Over a quarter (26.4%) of 
the comments did not seem to be either supporting or 
opposing the proposal and 39.5% of the comments had 
other themes included in which a code did not apply 
or could not be coded at all. Personal stories about 
cancer drove many comments across the overarching 
themes (supporting, opposing and neither supporting/
Table 3 Example and frequency of full text themes (n=45)*
Theme description Example %
Overall supporting renaming proposal 73.3
Evidence points to need for change ‘…the call follows a growing body of evidence that describing a condition 
using terms like 'cancer' can lead to an increased preference for more 
invasive treatments.’
100
Negative impact of the cancer label on 
patients
‘Using loaded labels such as ‘cancer’ can make patients more worried, 
the authors say, which can cause them to choose more aggressive 
management options—with more risk of harm.’
100
Importance of the need for further 
deliberation
‘Cancer Council Australia chief executive Sanchia Aranda yesterday said 
it was time for a global roundtable on whether the word cancer should be 
used when communicating with low- risk patients.’
26.6
Positive towards the feasibility of 
changing the cancer label
‘…the cancer label had already been removed from other tumours that 
evidence had clearly shown to be largely harmless.’
24.4
Doctors support the change ‘I think it's a great initiative,’ applauds Alvaro Rodríguez Lescure, vice 
president of the Spanish Society of Medical Oncology. ‘Once you describe 
an injury as cancer, the patient wants to cut it clean, even though it's not 
really needed, and you can do an annual ultrasound, for example,’ he 
argues.’
13.3
Overall opposing renaming proposal 2.2
Public education/better communication 
for patient instead of relabelling
‘An alternative approach would be to recalibrate the thresholds so 
some very low- risk cancers are categorised as benign. If the public was 
educated that benign signifies very low- risk rather than no risk at all, then 
anxiety- inducing labels could be avoided.’
24.4
Patients need to know the truth ‘The newish president of the Royal Australian College of General 
Practitioners Harry Nespolon says this proposal is dumbing down the 
advice given to patients. He says we always need to know the truth, the 
whole truth.’
20.0
Doctors concerns ‘But the concern about renaming cancer is that some patients may 
not be as diligent as they should be in managing their condition, like 
having regular screenings and check- ups… If people with these low- risk 
conditions drop- out of active surveillance the danger is that they will then 
develop invasive cancers that are too late to treat.’
13.3
Negative towards the feasibility of 
changing the cancer label
‘I think it is very important that the oncologists know the natural history of 
the various neoplasms…’
4.4
Overall neither supporting nor opposing proposal† 24.4
*Full text could have more than one theme applied.
†Combination of both the supporting and opposing themes.
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opposing). The mean word count for the comments was 
88 words (ranging from 5 to 607).
DISCUSSION
Overdiagnosis and overtreatment of cancer is a serious 
concern in modern healthcare.1 2 This is the first study 
to analyse the media and publics’ response to a proposal 
to rename low- risk cancers, a potential strategy to reduce 
overdiagnosis and overtreatment. Overall, we found that 
the coverage of the media reports was varied. Most full text 
articles and news stories reported the evidence well and 
tended to be positive towards the proposal. In all of the 
analysed media there was some reference to the evidence 
for why renaming low- risk cancers was being proposed 
and the potential harms associated with the cancer label. 
The articles and news stories often also highlighted the 
importance of the need for further deliberation before 
such a change could occur, the feasibility of the change, as 
well as concerns about the change and potential barriers 
to making the change. The public comments, however, 
tended to focus on the headlines, which were brief and 
usually framed the story around cancer generally.
Our study has important limitations and strengths. 
First, we were not able to access and analyse the majority 
of radio interviews and two Australian TV news stories 
from popular news programmes that were identified by 
Insentia Media Portal as the transcripts were not avail-
able in any of the databases or stored by The University 
of Sydney’s media team or the broadcaster. Retrospective 
access to such media is difficult, however, saving media 
prospectively using platforms which store Uniform 
Resource Locators (URLs) and webpages so that they 
cannot be broken or destroyed (eg, VV Impact Tracker or 
WebSatchel) may help avoid this issue in the future. We 
also tried our best to crosscheck the media sources using 
various databases (Google News, Factiva and Proquest) 
but there still may have been other media that was not 
captured in the analysis. The majority of the media was 
from Australia and New Zealand, which occupies a small 
proportion of the worldwide coverage. Furthermore, 
comments that were analysed only came from a very small 
proportion of the total reader/viewership. While these 
comments add value to the analysis and give an insight 
into aspects of public understanding and acceptability of 
these topics, it cannot be seen in any way to be represen-
tative of the public’s overall response. Lastly, although the 
analysis followed a robust process that has been success-
fully used by the study authors in the past, the coding 
framework was developed and the coding was carried out 
by two of the authors on The BMJ Analysis article and there-
fore may be subject to their views and biases on the topic. 
To our knowledge, however, this is the only study which 
has analysed the media’s coverage of low- risk cancers and 
topics related to overdiagnosis and overtreatment. The 
large amount of high- profile national and international 
media coverage that The BMJ Analysis article attracted 
Table 4 Example and frequency of comment themes (n=167)*†
Theme description Example %
Overall supporting renaming proposal 22.1
Unnecessary anxiety/overtreatment ‘I must say I agree with the re- labelling. I've personally seen a lot of 
damage and stress done to patients when they feel the need to act 
aggressively on neoplasia that is best left alone.’
13.2
Cancer is a spectrum ‘Some cancers are very slow growing and are less likely to kill you 
than say, a heart attack… I welcome the approach taken in the 
article.’
9.6
Overall opposing renaming proposal 49.7
Cancer is cancer ‘If it's cancer, it's cancer. Changing the word does not change the 
thing.’
19.2
Need for better education/communication ‘Surely rather than stop using the word cancer for cancer, we should 
instead educate the population that cancer doesn't=instant death.’
18.6
Can lead to negative implications ‘Under a microscope the cells have appearances of cancer. To 
pretend otherwise is to put at risk patients who will not understand 
this and avoid follow- up.’
9.0
Watchful waiting may cause anxiety ‘The intense anxiety of watchful waiting is stressful… Of course, 
treatment of the anxiety would also be desirable to avoid surgery, but 
I think we underestimate the harm of years/decades of anxiety about 
cancer progressing.’
2.4
Overall neither supporting nor opposing 26.4
Other comments/cannot be coded ‘The real reason? Your nanny state does not want to pay.’ 39.5
*Comments could have more than one theme applied.
†Not all media sources had public comments available, replies to original comments were excluded.
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meant that its messages were widely disseminated across 
mainstream and academic media sites and programmes. 
This meant that the public had the opportunity to read, 
view, listen and in some cases respond to the proposal 
to rename low- risk cancers. Using the well- established 
method of content analysis22 allowed us to make rigou-
rous judgements and valid inferences on the themes 
arising from the media reporting of our article.
How the media reports health and medical topics can 
have a profound influence on how the public perceives 
health risks and make decisions about their own 
health.20 21 Given the brevity of media headlines however, 
and their purpose to pull readers in, they cannot convey 
the complexity of the full article to readers. For some of 
those readers making comments, the dominant notion of 
cancer and individual’s previous experiences with cancer 
seemed to overshadow the article’s main messages. Many 
of those who responded felt that ‘cancer is cancer’ and 
renaming it would be concealing the truth from patients. 
Similar to previous findings,25 some of the public as well as 
clinicians who were interviewed in the media also believed 
that better public and patient education about the low- 
risk nature of some cancers could be a better strategy to 
curtail overdiagnosis and overtreatment. Acceptability 
and difficultly in understanding the strategy to rename 
low- risk cancers in order to avoid the harms associated 
with the cancer label and overdiagnosis and overtreat-
ment is not surprising. The general lack of awareness of 
these topics has been found across a number of recent 
studies25–31 and the highly positive and widespread public 
enthusiasm towards cancer screening and early detection 
has been documented.32 33 It is important to note that 
the underlying aim of the original Analysis article was to 
try and explain the complexities of the low- risk nature of 
some cancers and provide as much scientific data about 
the harms as well as the benefits of diagnosis and treat-
ment of low- risk cancers and the potential impact that 
comes from the cancer label. Communication that follows 
such an article or study may need to better provide the 
evidence in a way that people can relate to so that they 
become more generally aware of these risks and benefits. 
It also should be noted that the title of the original Anal-
ysis article was about ‘renaming’ low- risk cancers rather 
than ‘reclassifying’ or ‘recalibrating’ low- risk cancers 
which may have understandably led to a misinterpretation 
that we were advocating to just give these conditions new 
names and be deceptive to patients rather than thinking 
about or classifying the entire condition differently.
It has been shown that the concept of overdiagnosis is 
difficult to understand and highly emotive as it can often 
be driven by fear and discomfort with uncertainty.34 As 
such, overdiagnosis is often misunderstood or misinter-
preted.35 36 The media can play a major role in facilitating 
broader public discussion of the concept of overdiagnosis 
and overtreatment, potentially influencing public, patient 
and clinician beliefs, and health systems change.37 38 This 
study offers a novel insight into media coverage of the 
complex and counter- intuitive problem of overdiagnosis. 
It demonstrates the need for on- going deliberations 
about the optimum communication of similar topics to 
the public via mainstream media. Notably, future work 
specifically in the area of low- risk cancer communication 
will need to consider the powerful impact of people’s 
previous experience with a cancer diagnosis and the crit-
icism about being paternalistic and concealing the truth 
from patients, as this has also been shown in our focus 
group work on the topic.25 As new screening, testing 
and imaging technologies continue to emerge identi-
fying smaller and smaller cancerous lesions—many of 
which will be benign in biological behaviour—the need 
to design and evaluate strategies to inform and engage 
with the mainstream media and the public about cancer 
overdiagnosis risk is becoming more and more important.
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